This compound is primarily utilized in the field of medicinal chemistry and drug development. It serves as a key intermediate in the synthesis of potent and selective antagonists for specific biological targets, particularly in the treatment of neurological disorders and chronic pain management. Its structure, featuring trifluoromethyl groups and a thioureido moiety, enhances its binding affinity and metabolic stability, making it valuable for optimizing pharmacokinetic properties in drug candidates. Additionally, it is employed in research to study receptor-ligand interactions, aiding in the design of novel therapeutic agents. Its role in the development of small-molecule inhibitors also extends to oncology, where it contributes to the creation of targeted cancer therapies.